- /
- Supported exchanges
- / US
- / HYFT.NASDAQ
ImmunoPrecise Antibodies Ltd. (HYFT NASDAQ) stock market data APIs
ImmunoPrecise Antibodies Ltd. Financial Data Overview
MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with ImmunoPrecise Antibodies Ltd. (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get ImmunoPrecise Antibodies Ltd. data using free add-ons & libraries
Get ImmunoPrecise Antibodies Ltd. Fundamental Data
ImmunoPrecise Antibodies Ltd. Fundamental data includes:
- Net Revenue: 16 231 K
- EBITDA: -16 097 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get ImmunoPrecise Antibodies Ltd. Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-09-14
- EPS/Forecast: -0.05
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ImmunoPrecise Antibodies Ltd. News
New
MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies
Senior appointments from Pfizer, Novartis, Arbor Biotechnologies, and Orum Therapeutics bring preclinical development, structural biology, and portfolio strategy depth as MindWalk prepares its program...
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
Equity Insider News Commentary AUSTIN, Texas, Oct. 1, 2026 /PRNewswire/ -- Towards Healthcare projects that the global AI in drug discovery market will grow from $19.89 billion in 2025 to $160.49 bil...
MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director
Veteran Banker and Licensed Fiduciary to Serve on the Audit Committee and the Compensation, Nomination and Governance Committee AUSTIN, Texas, October 01, 2026--(BUSINESS WIRE)--MindWalk Holdings Cor...
What Is Advanced Micro Devices (AMD) Proving In Edge AI And Life Sciences?
Advanced Micro Devices (NasdaqGS:AMD) and Advantech announced a collaboration to accelerate Edge AI workloads using AMD embedded and GPU platforms. MindWalk has moved OpenFold3 into production on AMD ...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.